Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00706875
What this trial is testing

A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors

Who this might be right for
Uterine CancerCervix Uteri NosGestational Trophoblastic Disease
Memorial Sloan Kettering Cancer Center 59
Testing effectiveness (Phase 2)Looking for participantsNCT07680205
What this trial is testing

An Experimental Study of Belzutifan Impact on Catecholamine Metabolism

Who this might be right for
Pheochromocytoma and Paraganglioma (PPGL)Pheochromocytoma MalignantPheochromocytoma, Metastatic+2 more
Cambridge University Hospitals NHS Foundation Trust 12
Not applicableStudy completedNCT00797602
What this trial is testing

Proton Therapy for Chordomas and/or Chondrosarcomas

Who this might be right for
ChordomasChondrosarcomas
University of Florida 189
Testing effectiveness (Phase 2)Looking for participantsNCT06172595
What this trial is testing

FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade Glioma

Who this might be right for
Glioma, Malignant
Singapore General Hospital 22
Not applicableStudy completedNCT00297895
What this trial is testing

Multicenter Selective Lymphadenectomy Trial II (MSLT-II)

Who this might be right for
Melanoma
Saint John's Cancer Institute 1,939
Testing effectiveness (Phase 2)Study completedNCT02379195
What this trial is testing

Peginterferon and TIL Therapy for Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Inge Marie Svane 12
Early research (Phase 1)Study completedNCT02858869
What this trial is testing

Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic MelanomaMucosal Melanoma+4 more
Emory University 25
Testing effectiveness (Phase 2)Looking for participantsNCT06794645
What this trial is testing

Pembrolizumab and Pemetrexed for Progressive Chordoma

Who this might be right for
ChordomasChordoma
Saint John's Cancer Institute 21
Testing effectiveness (Phase 2)Ended earlyNCT01369875
What this trial is testing

Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 2
Not applicableUnknownNCT04136470
What this trial is testing

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

Who this might be right for
Non Small Cell Lung CancerMicrobiomeMetagenome+2 more
Ardigen 130
Early research (Phase 1)Study completedNCT01576666
What this trial is testing

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Who this might be right for
Dose EscalationSafetyPreliminary Efficacy+9 more
Novartis Pharmaceuticals 120
Testing effectiveness (Phase 2)Ended earlyNCT00671554
What this trial is testing

Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma

Who this might be right for
Melanoma
Prisma Health-Upstate 3
Testing effectiveness (Phase 2)Looking for participantsNCT05092451
What this trial is testing

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

Who this might be right for
B-Cell LymphomaMyelodysplastic Syndromes (MDS)Acute Myeloid Leukemia (AML)+7 more
M.D. Anderson Cancer Center 80
Not applicableLooking for participantsNCT02686229
What this trial is testing

Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade Gliomas

Who this might be right for
Glioma
University of Ulm 300
Large-scale testing (Phase 3)Looking for participantsNCT04799002
What this trial is testing

Topotecan and Melphalan for Retinoblastoma

Who this might be right for
RetinoblastomaChemotherapy Effect
Sun Yat-sen University 50
Not applicableEnded earlyNCT00589095
What this trial is testing

Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities

Who this might be right for
Glioblastoma Multiforme
Yale University 5
Early research (Phase 1)Ended earlyNCT01400672
What this trial is testing

Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma

Who this might be right for
Diffuse Intrinsic Pontine Glioma
Masonic Cancer Center, University of Minnesota 8
Testing effectiveness (Phase 2)Study completedNCT03008369
What this trial is testing

Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery

Who this might be right for
Malignant Adrenal Gland PheochromocytomaMalignant ParagangliomaMetastatic Adrenal Gland Pheochromocytoma
Mayo Clinic 3
Not applicableLooking for participantsNCT01109394
What this trial is testing

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

Who this might be right for
SarcomaEndocrine TumorsNeuroblastoma+2 more
National Cancer Institute (NCI) 6,035
Early research (Phase 1)Study completedNCT02575794
What this trial is testing

Terameprocol in Treating Patients With Recurrent High Grade Glioma

Who this might be right for
High Grade Glioma (III or IV)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Next Page